Condition

Gram-negative Bacterial Infection clinical trials and research

• 2Clinical trials
• 10Countries

All recruiting trials (2)

• Different dosing schedules of ceftazidime‑avibactam plus aztreonam for carbapenem‑resistant Gram‑negative infections

  This trial tests different dosing schedules of ceftazidime‑avibactam plus aztreonam to see which works best for adults with metallo‑β‑lactamase–producing, carbapenem‑resistant Gram‑negative infections.

  Recruiting Phase 4 The First Affiliated Hospital with Nanjing Medical University · Nanjin, Jiangsu · NCT07478484

• Evaluating Aztreonam-Avibactam for Treating Bacterial Infections in Infants and Newborns

  This study is testing a new antibiotic combination to see if it is safe and effective for treating bacterial infections in hospitalized infants and newborns.

  Recruiting at 30 sites Phase 2 Pfizer · Orange, California and 31 other locations · NCT06462235

Quick answers

How many Gram-negative Bacterial Infection clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in Argentina (1 trial), Bulgaria (1 trial), Greece (1 trial), India (1 trial), Israel (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →